You are here » Home » Companies » Company Overview » Advik Laboratories Ltd

Advik Laboratories Ltd.

BSE: 531686 Sector: Health care
NSE: N.A. ISIN Code: INE537C01019
BSE LIVE 15:16 | 09 Dec 5.75 0.19
(3.42%)
OPEN

5.56

HIGH

5.80

LOW

5.56

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 5.56
PREVIOUS CLOSE 5.56
VOLUME 1600
52-Week high 15.42
52-Week low 4.50
P/E
Mkt Cap.(Rs cr) 10.99
Buy Price 5.40
Buy Qty 100.00
Sell Price 0.00
Sell Qty 0.00
OPEN 5.56
CLOSE 5.56
VOLUME 1600
52-Week high 15.42
52-Week low 4.50
P/E
Mkt Cap.(Rs cr) 10.99
Buy Price 5.40
Buy Qty 100.00
Sell Price 0.00
Sell Qty 0.00

Advik Laboratories Ltd. (ADVIKLABS) - Company History

Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. Advik Laboratories Limited has a technical collaboration with PFC Pharma Focus Ltd. The company is based in New Delhi, India. It also markets its products in the Middle East, South America, and Africa. Advik Laboratories Limited was promoted in the 1994 by Jain along with a group of dedicated professionals. The company commenced commercial production in 1997. In his leadership, the company has witnessed a fast growth rate, without compromise to quality. During the year 2003-2004, the company established their brand, Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005, the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa, Robial, Chewfe-C, Stibomin, Wibatol, Wibatol-O, Twosum, and Arfagel. During the year 2005-2006, the company bagged Govt. supply contracts from Govt. of Andhra Pradesh and Kerala Govt. for supply of Paracetamol. The company executed both the contracts on time. During the year 2007-2008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level.

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard